In-Kyu Park Professor

Chonnam National University Hwasun Hospital (11.2012. MOU) Department of Biomedical Science, Chonnam National University Medical School
Regenerative medicine, Drug Delivery System

Won Jong Kim Professor

Department of Chemistry, POSTECH
Biopolymer, Drug Delivery System, Gene Carrier, Biotechnology, Tissue Engineering

Hyung Soo Han Professor

Kyungpook National University School of Medicine Department of Physiology /
Head of Molecular DiagnosisㆍImaging Research Institute
Neurology, neuroscience

Soo-Hong Lee Professor

Department of Biomedical Science, CHA University
Biopolymer, Tissue Engineering, Stem Cell Engineering

Hae Shin Lee Professor

Department of Chemistry, KAIST
Biomedical Engineering, Nanoparticle Synthesis, Protein Therapeutics, Biointerface

Jin Seok Kim Professor

Industry Academic Cooperation Foundation of Sookmyung Women’s University
(03.2016. MOU) Industrial Pharmacy(practical pharmacy), Sookmyung Women’s University College of Pharmacy
/ Head of Health Care Center
Research of New Fomulation, Drug Delivery System

Byeong-il Lee Chief

Medical Photonics Research center of Korea Photonics Technology Institute
(04.2016. MOU) Medical Photonics Research center of Korea Photonics Technology Institute
Nuclear medicine, Phontonics molecular imaging, Fluorescent probe, Photonics diagnosis,

Tae-Jong Yoon Professor

Ajou University College of Pharmacy (05.2016. MOU ) Ajou University College of Pharmacy
Nanomaterials, Bio-imaging and sensing, Drug delivery

YoungSoo Kim Professor

College of Pharmacy Yonsei university
Chemical Biology
Neurodegenerative Disorders
Industrial Bioconvergence
Lab on Biochemistry and Molecular Biology

SangYeul Lee Ph. D

BioActs
Chemistry
Organic Synthesis
Chemical Methodology
Pharmaceutical Chemistry

Hyeon-gu Kim Professor

Professor Kim completed master in medicine and MD degree in surgery from Korea University medical school. After that, he finished a resident course in thoracic surgery and became an associate professor in the department of Thoracic surgery at Korea University Guro Hospital. Since 2015, he has served as professor and the director of Thoracic surgery at Korea University Guro Hospital. As a surgeon, he performed more than 100 cases of 2-port VATS lobectomy for lung cancer, which might be the largest number in Korea. Dr Kim successfully performed single-port VATS lobectomy, utilizing a single-port thoracoscope, for the first in Korea and second in the world. In addition, his expertise is involved in a variety of fields such as an expert committee member of the Ministry of Food and Drug Safety (medical devices) and the New Medical Technology Evaluation Committee of the Korea Institute of Health and Medical Research. He also serves as a director/academic member of the Society of Thoracic and Cardiovascular Surgery.

Se-Hoon Kim Dr.

Dr. Kim got Ph. D. degree in engineering at the Department of Materials Science and Engineering, Seoul National University. He served as a joint professor of graduate school of Science and Technology (UST) and the convergence graduate school of Korea university and KIST. Currently, he is a senior researcher at the Theranostics Research Center in KIST. His research interest involves not only theranostics also development of bio-imaging materials such as fluorescence sensors, biosensors and drug delivery vehicles. His recent research fields are the development of novel, high-performing organic and inorganic materials for nano-biophotonics

Sang Yeul Lee Dr.

Dr. Lee got bachelor’s degree in chemistry at the University of California, Berkeley and Ph. D. degree in organic chemistry at The Scripps Research Institute under the guidance of Professor Dale L. Boger. He worked as an acting direct of research center at Taejoon Pharmaceutical, a researcher at KIST and research professor at Sogang and Hanyang university. Currently, he is a technical advisor of BioActs Co. He is an expert in organic and medicinal chemistry, and his research fields are natural products synthesis, organic methodology development and the development of medicines for degenerative diseases and cancers.

Tae-gyu Nam Professor

Professor Nam Tae-gyu completed his bachelor's and master's degrees at Seoul National University's College of Pharmacy and joined as a researcher at LG Life Science Research Institute. During the time, he participated in the development of Factive, a quinolone antibiotic, which the first U.S. FDA approved domestically development new drug. After that, moved to the US and began doctoral studies in the Department of Environ-mental Sciences and Engineering at the University of North Carolina-Chapel Hill, and transferred to the Department of Chemistry at Vanderbilt University following year, where he finished his doctoral study in bioorganic chemistry of topical and lipid peroxidation under the guidance of Professor Ned A. Porter. In 2006, he joined a functional genomics project utilizing High Throughput Screening system at the Genomics Institute of the Novartis Research Foundation (GNF) under the guidance of Professor Peter G. Schultz at The Scripps Research Institute. Return to Korea in 2009, he established Korea's largest organic compound library and HTS system at the Gyeonggi Biocenter and carried out a new drug development project. In 2011, he was appointed as a faculty at Hanyang University's College of Pharmacy, and he currently holds as a vice president of convergence institute at ERICA campus.